Quantitative spatial profiling of PD-1/PD-L1 interaction and HLA-DR/IDO-1 predicts improved outcomes of anti–PD-1 therapies in metastatic melanoma. Johnson, D. B, Bordeaux, J., Kim, J. Y., Vaupel, C., Rimm, D. L, Ho, T. H, Joseph, R. W, Daud, A. I, Conry, R. M, Gaughan, E. M, & others Clinical Cancer Research, 24(21):5250–5260, American Association for Cancer Research, 2018.
bibtex   
@article{johnson2018quantitative,
  title={Quantitative spatial profiling of PD-1/PD-L1 interaction and HLA-DR/IDO-1 predicts improved outcomes of anti--PD-1 therapies in metastatic melanoma},
  author={Johnson, Douglas B and Bordeaux, Jennifer and Kim, Ju Young and Vaupel, Christine and Rimm, David L and Ho, Thai H and Joseph, Richard W and Daud, Adil I and Conry, Robert M and Gaughan, Elizabeth M and others},
  journal={Clinical Cancer Research},
  volume={24},
  number={21},
  pages={5250--5260},
  year={2018},
  publisher={American Association for Cancer Research}
}

Downloads: 0